PRAXIS PRECISION MEDICINES, INC. Share-based Payment Arrangement, Decrease for Tax Withholding Obligation
PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Share-based Payment Arrangement, Decrease for Tax Withholding Obligation of $310.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-06
- PRAXIS PRECISION MEDICINES, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-06-30 was $310.00K, a 1247.83% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2026-03-31 was $12.92M, a 981.42% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-09-30 was $52.00K, a 5100.00% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. share-based payment arrangement, decrease for tax withholding obligation for the quarter ending 2025-06-30 was $23.00K, a 76.92% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2025 was $2.09M, a 578.25% increase from fiscal 2024.
- PRAXIS PRECISION MEDICINES, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2024 was $308.00K, a 124.82% increase from fiscal 2023.
- PRAXIS PRECISION MEDICINES, INC. share-based payment arrangement, decrease for tax withholding obligation for fiscal 2023 was $137.00K.
| Period end | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 3 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 6 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 9 month | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation 12 month |
|---|---|---|---|---|
| 2026-06-30 | $310.00K 10-Q · filed 2026-08-06 | $13.23M derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | $12.92M 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $2.09M 10-K · filed 2026-02-19 | |||
| 2025-09-30 | $52.00K 10-Q · filed 2025-11-05 | $75.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.27M derived: sum of 3 quarters · filed 2026-08-06 | $1.43M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $23.00K 10-Q · filed 2026-08-06 | $1.22M derived: sum of 2 quarters · filed 2026-08-06 | $1.38M derived: sum of 3 quarters · filed 2026-08-06 | $1.38M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $1.20M 10-Q · filed 2026-08-06 | $1.35M derived: sum of 2 quarters · filed 2026-08-06 | $1.35M derived: sum of 3 quarters · filed 2026-08-06 | $1.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2024-12-31 | $157.00K 10-K · filed 2025-02-28 | $158.00K derived: sum of 2 quarters · filed 2025-11-05 | $171.00K derived: sum of 3 quarters · filed 2025-11-05 | $308.00K 10-K · filed 2026-02-19 |
| 2024-09-30 | $1.00K 10-Q · filed 2025-11-05 | $14.00K derived: sum of 2 quarters · filed 2025-11-05 | $151.00K derived: sum of 3 quarters · filed 2025-11-05 | $156.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $13.00K 10-Q · filed 2025-11-05 | $150.00K derived: sum of 2 quarters · filed 2025-11-05 | $155.00K derived: sum of 3 quarters · filed 2025-11-05 | $156.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-03-31 | $137.00K 10-Q · filed 2025-11-05 | $142.00K derived: sum of 2 quarters · filed 2025-11-05 | $143.00K derived: sum of 3 quarters · filed 2025-11-05 | $147.00K derived: sum of 4 quarters · filed 2025-11-05 |
| 2023-12-31 | $5.00K 10-K · filed 2025-02-28 | $6.00K derived: sum of 2 quarters · filed 2025-02-28 | $10.00K derived: sum of 3 quarters · filed 2025-02-28 | $137.00K 10-K · filed 2026-02-19 |
| 2023-09-30 | $1.00K 10-K · filed 2025-02-28 | $5.00K derived: sum of 2 quarters · filed 2025-02-28 | $132.00K derived: sum of 3 quarters · filed 2025-02-28 | $139.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $4.00K 10-K · filed 2025-02-28 | $131.00K derived: sum of 2 quarters · filed 2025-02-28 | $138.00K derived: sum of 3 quarters · filed 2025-02-28 | $144.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $127.00K 10-K · filed 2025-02-28 | $134.00K derived: sum of 2 quarters · filed 2025-02-28 | $140.00K derived: sum of 3 quarters · filed 2025-02-28 | $157.00K derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $7.00K 10-K · filed 2024-03-05 | $13.00K derived: sum of 2 quarters · filed 2024-03-05 | $30.00K derived: sum of 3 quarters · filed 2024-03-05 | $260.00K derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-09-30 | $6.00K 10-K · filed 2024-03-05 | $23.00K derived: sum of 2 quarters · filed 2024-03-05 | $253.00K derived: sum of 3 quarters · filed 2024-03-05 | |
| 2022-06-30 | $17.00K 10-K · filed 2024-03-05 | $247.00K derived: sum of 2 quarters · filed 2024-03-05 | ||
| 2022-03-31 | $230.00K 10-K · filed 2024-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |